BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Dec 03, 15:54Prev. Close
4.82
Open Price
4.89
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4.70 (2500)
| Key Financial Ratios of Ajooni Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.20 | 0.25 | 1.94 | 1.05 | 0.37 | |
| Diluted EPS (Rs.) | 0.20 | 0.25 | 1.94 | 1.05 | 0.37 | |
| Cash EPS (Rs.) | 0.26 | 0.35 | 0.24 | 2.16 | 0.95 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 5.11 | 4.87 | 4.76 | 16.37 | 15.64 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 5.11 | 4.87 | 4.76 | 16.37 | 15.64 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 6.66 | 9.14 | 8.50 | 74.00 | 51.01 | |
| PBDIT/Share (Rs.) | 0.33 | 0.51 | 0.35 | 3.11 | 1.66 | |
| PBIT/Share (Rs.) | 0.27 | 0.41 | 0.23 | 2.00 | 1.09 | |
| PBT/Share (Rs.) | 0.25 | 0.34 | 0.18 | 1.46 | 0.50 | |
| Net Profit/Share (Rs.) | 0.20 | 0.25 | 0.13 | 1.05 | 0.37 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 5.01 | 5.52 | 4.10 | 4.20 | 3.26 | |
| PBIT Margin (%) | 4.06 | 4.43 | 2.75 | 2.70 | 2.13 | |
| PBT Margin (%) | 3.77 | 3.73 | 2.11 | 1.97 | 0.98 | |
| Net Profit Margin (%) | 2.94 | 2.69 | 1.50 | 1.41 | 0.73 | |
| Return on Networth / Equity (%) | 3.82 | 5.06 | 2.69 | 6.40 | 2.38 | |
| Return on Capital Employed (%) | 5.16 | 7.98 | 4.72 | 10.55 | 6.20 | |
| Return on Assets (%) | 3.54 | 4.54 | 1.91 | 3.61 | 1.33 | |
| Total Debt/Equity (X) | 0.06 | 0.05 | 0.12 | 0.33 | 0.43 | |
| Asset Turnover Ratio (%) | 1.61 | 1.51 | 1.70 | 2.60 | 182.11 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 12.86 | 10.74 | 2.28 | 2.18 | 2.05 | |
| Quick Ratio (X) | 7.89 | 5.63 | 1.82 | 1.60 | 1.53 | |
| Inventory Turnover Ratio (X) | 5.83 | 6.25 | 10.27 | 11.35 | 9.49 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 95.06 | 53.43 | 39.48 | 72.63 | 36.96 | |
| EV/Net Operating Revenue (X) | 0.83 | 0.67 | 0.53 | 0.98 | 0.72 | |
| EV/EBITDA (X) | 16.51 | 12.07 | 12.90 | 23.34 | 22.19 | |
| MarketCap/Net Operating Revenue (X) | 0.84 | 0.65 | 0.46 | 0.91 | 0.60 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.10 | 1.21 | 0.83 | 4.11 | 1.94 | |
| Price/Net Operating Revenue | 0.84 | 0.65 | 0.46 | 0.91 | 0.60 | |
| Earnings Yield | 0.03 | 0.04 | 0.03 | 0.02 | 0.01 |
21.08.2025
Ajooni Biotech Standalone June 2025 Net Sales at Rs 31.27 crore, up 21.86% Y-o-Y
27.11.2024
Ajooni Biotech Standalone September 2024 Net Sales at Rs 25.72 crore, up 32.06% Y-o-Y
13.08.2024
Ajooni Biotech Standalone June 2024 Net Sales at Rs 25.66 crore, up 22.17% Y-o-Y
29.05.2024
Ajooni Biotech Standalone March 2024 Net Sales at Rs 19.58 crore, down 52.54% Y-o-Y
21.08.2025
Ajooni Biotech Standalone June 2025 Net Sales at Rs 31.27 crore, up 21.86% Y-o-Y
27.11.2024
Ajooni Biotech Standalone September 2024 Net Sales at Rs 25.72 crore, up 32.06% Y-o-Y
13.08.2024
Ajooni Biotech Standalone June 2024 Net Sales at Rs 25.66 crore, up 22.17% Y-o-Y
29.05.2024
Ajooni Biotech Standalone March 2024 Net Sales at Rs 19.58 crore, down 52.54% Y-o-Y